FDA Approves Baxter’s Advate for Routine Prophylaxis in Adults, Children With Hemophilia A

Baxter International announced that the FDA has approved Advate [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.
Yahoo! Finance